| Application no. and date | 17806608.0 (espacenet) (Federated) (European Patent Register), 20170529 | | Patent/reg. no. and date | DK/EP 3480307, 20210623 | | Publication date | 20190508 | | Priority no. and date | JP 2016107481, 20160530 | | EP pub. no. and date |
EP 3480307 20190508 | | Effective date | | | Applicant/owner | National University Corporation Tottori University, 101 Koyamacho-Minami 4-chome
Tottori-shi
Tottori 680-8550, JP,
Astellas Pharma Inc., 5-1, Nihonbashi-Honcho
2-chome
Chuo-ku
Tokyo 103-8411, JP | | Applicant ref. no. | P77091DK01 | | Inventor | NAKAO, Shinsuke, c/o Astellas Pharma Inc.
5-1, Nihonbashi-Honcho 2-chome
Chuo-ku
Tokyo 103-8411, JP,
KAWASE, Tatsuya, c/o Astellas Pharma Inc.
5-1, Nihonbashi-Honcho 2-chome
Chuo-ku
Tokyo 103-8411, JP,
NAKAMURA, Takafumi, c/o National University Corporation
Tottori University
86, Nishi-cho
Yonago-shi
Tottori 683-8503, JP | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 35/768 (2015.01) , A61P 35/00 (2006.01) , A61P 35/02 (2006.01) , A61P 37/04 (2006.01) , C12N 15/09 (2006.01) , C12N 7/01 (2006.01) | | Title | NY GENETISK MODIFICERET VACCINIAVIRUS | | Int. application no. | JP2017019921 | | Int. publication no. | WO2017209053 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
